tiprankstipranks
Trending News
More News >
Scorpius Holdings (SCPX)
OTHER OTC:SCPX
Advertisement

Scorpius Holdings (SCPX) AI Stock Analysis

Compare
2,649 Followers

Top Page

SCPX

Scorpius Holdings

(OTC:SCPX)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - 4o)
Rating:40Underperform
Price Target:
$0.00
▼(-100.00% Downside)
Scorpius Holdings' overall stock score is primarily impacted by its poor financial performance, characterized by declining revenue, persistent losses, and high leverage. The technical analysis indicates bearish momentum, with the stock trading below key moving averages and showing overbought signals. Valuation metrics are weak, with no earnings or dividend yield, reflecting market concerns about the company's future prospects.

Scorpius Holdings (SCPX) vs. SPDR S&P 500 ETF (SPY)

Scorpius Holdings Business Overview & Revenue Model

Company DescriptionScorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
How the Company Makes MoneyScorpius Holdings generates revenue through multiple streams, primarily by investing in and managing a portfolio of subsidiaries across its core sectors. The company earns income from technology services by providing software solutions and consulting to businesses looking to enhance their operational efficiency. In the renewable energy space, SCPX profits from the development and management of energy projects, capitalizing on government incentives and market demand for sustainable energy sources. Additionally, the financial services arm contributes significantly to revenue through fees and commissions derived from financial advisory, investment management, and transaction services. Strategic partnerships with other firms and government entities further enhance SCPX's earning potential, allowing them to capitalize on emerging opportunities in their target markets.

Scorpius Holdings Financial Statement Overview

Summary
Scorpius Holdings is facing significant financial challenges, with declining revenue, persistent losses, and high leverage. The negative net income and volatile profit margins highlight operational inefficiencies. While the balance sheet shows some stability with positive equity, the reliance on debt financing poses risks. Cash flow management remains a critical area for improvement.
Income Statement
30
Negative
Scorpius Holdings has faced declining revenue over the past year, with a notable decrease of 10.75% from 2023 to 2024. The company has consistently reported negative net income, resulting in a negative net profit margin. Additionally, the gross profit margin has been volatile, indicating challenges in cost management. The EBIT and EBITDA margins are also negative, reflecting ongoing operational inefficiencies.
Balance Sheet
40
Negative
The company's balance sheet shows high leverage, with a debt-to-equity ratio of 4.53 in 2024, indicating significant reliance on debt financing. The equity ratio has decreased over the years, suggesting a shrinking equity base. However, the company maintains a positive stockholders' equity, which provides some financial stability.
Cash Flow
35
Negative
Scorpius Holdings has experienced negative free cash flow, although there was a slight improvement in 2024 compared to 2023. The operating cash flow remains negative, and the free cash flow to net income ratio is unfavorable, indicating challenges in generating cash from operations. The company has relied on financing activities to support its cash flow needs.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.94M6.24M6.99M5.98M2.11M2.95M
Gross Profit-1.52M3.05M-2.22M-420.02K1.42M2.95M
EBITDA-33.02M-26.22M-33.99M-39.29M-34.86M-24.59M
Net Income-39.10M-32.81M-45.22M-43.43M-35.07M-26.05M
Balance Sheet
Total Assets23.59M39.18M51.04M104.40M120.96M124.19M
Cash, Cash Equivalents and Short-Term Investments249.16K2.38M2.39M39.03M96.38M111.77M
Total Debt20.75M28.55M14.04M9.30M1.93M1.85M
Total Liabilities30.15M37.50M22.74M31.96M8.93M8.70M
Stockholders Equity-1.37M6.30M31.40M73.92M113.11M116.24M
Cash Flow
Free Cash Flow-25.33M-26.88M-33.52M-25.82M-40.03M-22.36M
Operating Cash Flow-24.69M-26.01M-31.53M-5.70M-38.13M-22.02M
Investing Cash Flow-1.55M1.21M32.24M10.99M9.77M-95.42M
Financing Cash Flow24.88M25.64M-8.95M-4.91M25.49M119.33M

Scorpius Holdings Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.03
Negative
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
66.92
Neutral
STOCH
93.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCPX, the sentiment is Neutral. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.02, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 66.92 is Neutral, neither overbought nor oversold. The STOCH value of 93.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SCPX.

Scorpius Holdings Risk Analysis

Scorpius Holdings disclosed 48 risk factors in its most recent earnings report. Scorpius Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Scorpius Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$1.19M0.29306.41%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
$36.69K-69.81%88.78%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCPX
Scorpius Holdings
0.02
-0.72
-97.30%
SCNI
Scinai Immunotherapeutics
1.27
-2.38
-65.21%
ADTX
Aditxt
6.51
-13,835.99
-99.95%
CERO
CERo Therapeutics Holdings
0.12
-150.08
-99.92%
PBM
Psyence Biomedical
3.00
-37.41
-92.58%
CDT
Conduit Pharmaceuticals
2.50
-1,179.50
-99.79%

Scorpius Holdings Corporate Events

Business Operations and StrategyLegal Proceedings
Scorpius Holdings Faces Asset Sale Due to Defaults
Negative
Oct 21, 2025

On October 10, 2025, Scorpius Holdings, Inc. received a Notice of Public Disposition due to defaults on senior secured convertible notes and other promissory notes, totaling obligations exceeding $26 million. As a result, the collateral agent will conduct a public sale of the company’s pledged assets, including significant stakes in Scorpius Biomanufacturing, Inc. and Skunkworx Bio, Inc., on November 12, 2025, to address these financial obligations.

Business Operations and StrategyPrivate Placements and Financing
Scorpius Holdings Secures Additional $5M Loan Agreement
Neutral
Oct 8, 2025

On October 1, 2025, Scorpius Holdings, Inc. issued a non-convertible promissory note for $500,083 to an institutional investor, with a 5% annual interest rate, maturing by October 31, 2025, or upon certain events. The company also entered into an Amendment Agreement on October 6, 2025, allowing for additional loans up to $5 million, with notes accruing 5% interest and maturing within six months or upon specific events. These financial maneuvers are aimed at securing the company’s obligations under existing and future promissory notes, potentially impacting its financial strategy and stakeholder relations.

Executive/Board Changes
Scorpius Holdings Appoints Kit Foo Chye as Director
Neutral
Oct 1, 2025

On September 22, 2025, Scorpius Holdings, Inc. appointed Kit Foo Chye as a director. Mr. Chye, with extensive experience in corporate finance, currently serves as the Head of Corporate Finance at JS Group and has held significant roles in various companies since 2005. His appointment does not involve any committee memberships or material interests in transactions with the company.

Private Placements and Financing
Scorpius Holdings Issues Promissory Note to Investor
Neutral
Sep 25, 2025

On September 22, 2025, Scorpius Holdings, Inc. issued a non-convertible promissory note valued at $128,000 to an institutional investor. The note, which accrues interest at 5% per annum, is set to mature on October 31, 2025, or upon the occurrence of a corporate event or default. The issuance was made under an exemption from registration requirements, reflecting the company’s strategic financial maneuvering to manage its obligations.

The most recent analyst rating on (SCPX) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Scorpius Holdings stock, see the SCPX Stock Forecast page.

Private Placements and Financing
Scorpius Holdings Issues Promissory Note to Investor
Neutral
Sep 19, 2025

On September 12, 2025, Scorpius Holdings, Inc. issued a non-convertible promissory note valued at $471,000 to an institutional investor. The note, which accrues interest at 5% per annum, is set to mature on October 31, 2025, or upon the occurrence of a corporate event or default. The issuance was made under an exemption from registration requirements, allowing the company flexibility in its financial operations.

The most recent analyst rating on (SCPX) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Scorpius Holdings stock, see the SCPX Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Scorpius Holdings Issues $500K Promissory Note
Neutral
Sep 2, 2025

On August 29, 2025, Scorpius Holdings issued a non-convertible promissory note worth $500,000 to an institutional investor. The note, which accrues interest at 5% per annum, is set to mature by October 31, 2025, or upon the occurrence of a corporate event or default. This financial maneuver allows the holder to demand redemption of the note using proceeds from any subsequent financing, reflecting Scorpius Holdings’ strategic financial management to bolster its operations.

The most recent analyst rating on (SCPX) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Scorpius Holdings stock, see the SCPX Stock Forecast page.

Scorpius Holdings Delays Q2 2025 Financial Report
Aug 14, 2025

Scorpius Holdings, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The company cites time constraints on management as the primary reason for the delay, which has made it impractical to file the report without undue hardship and expense. Scorpius Holdings anticipates filing the delayed report within five calendar days following the prescribed due date. The company expects a decrease in revenue and an increase in net loss compared to the same quarter last year, although specific figures are not yet available. Scorpius Holdings is actively working on compliance and the notification is signed by William Ostrander, the Chief Financial Officer.

The most recent analyst rating on (SCPX) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Scorpius Holdings stock, see the SCPX Stock Forecast page.

Private Placements and Financing
Scorpius Holdings Issues $490,000 Promissory Note
Neutral
Jul 30, 2025

On July 25, 2025, Scorpius Holdings issued a non-convertible promissory note worth $490,000 to an institutional investor, accruing interest at 5% per annum. The note, maturing on September 30, 2025, or upon a corporate event or default, includes a 5% premium payment on the principal at maturity. The note allows the holder to demand redemption using proceeds from any subsequent financing, and was sold under an exemption from registration requirements.

The most recent analyst rating on (SCPX) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Scorpius Holdings stock, see the SCPX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 21, 2025